Women with cancer tend to live longer than men, according to a large study published in the Journal of the National Cancer ...

A new study has found that a commonly prescribed anti-nausea medication is associated with a better prognosis for women with early-stage breast cancer, particularly triple-negative breast cancer.

Aprepitant is associated with improved survival outcomes in early-stage breast cancer, particularly in triple-negative cases, showing significant DDFS and BCSS improvements. The study analyzed 13,811 ...

The increase in median overall survival among women treated with IMNN-001 in the OVATION 2 trial rose from the previously ...

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and more frequent adverse events. The study used the Dutch BioCAPTURE registry ...

Asymptomatic women with moderate-to-severe aortic regurgitation and preserved left ventricular (LV) function managed without surgery had lower survival rates than their male counterparts, although ...

For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been ...

The greatest mortality differences between women and men with stage 5 CKD occurred at ages younger than 65 years. In the general population, women tend to outlive men of the same age. However, among ...